AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Risankizumab for Ulcerative Colitis
JAMA Author Interviews
Intro
Exploring the latest FDA-approved medications and treatment options for patients with moderate to severe ulcerative colitis, aiming to induce and maintain remission to prevent inflammation reactivation.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode